Drugs / Piperacillin/Tazobactam
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06977347 Background | Jun 2025 → Dec 2026 expected | bacterial infectious disease | CHOSEOK YOON | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/Tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06977347 ↗ |
| Route | Intravenous | “Piperacillin/tazobactam: 4.5g IV q6h (over 3h)” NCT06977347 ↗ |